Trend Direction
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) decreased from FY2025 to FY2026, moving from $1,253,293 to $15,337 in the ingested records.
- Latest: $15,337
- Previous: $1,253,293
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
NAICS 541714 includes $915,145,769 in federal contract obligations across 55 ingested award records.
Quick answer
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) has $915,145,769 in ingested federal contract obligations across 55 award records in this naics profile.
NAICS Snapshot
Total obligations$915,145,769
Award records55
Entity code541714
Data updatedMay 7, 2026
Top relationshipEMERGENT BIODEFENSE OPERATIONS LANSING LLC
Top categoryDepartment of Health and Human Services
Source: USAspending.gov. Last updated from ingested federal spending data: May 7, 2026.
Market Analysis
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) has $915,145,769 across 55 ingested award records, with the analysis below generated only from visible tables on this page.
Concentration
EMERGENT BIODEFENSE OPERATIONS LANSING LLC accounts for 23.1% of RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)'s visible obligations in this slice, which is the first concentration signal to review before treating the market as broad or fragmented.
- Top relationship: EMERGENT BIODEFENSE OPERATIONS LANSING LLC
- Top value: $211,409,788
Buyer And Category Mix
Department of Health and Human Services is the largest visible secondary category at $783,000,952. Use this alongside the relationship table to separate one-off award activity from repeat market exposure.
- Largest secondary category: Department of Health and Human Services
- Category value: $783,000,952
Recent Award Signal
The latest displayed award is 75A50122C00047 from FY2023 with $211,409,788 in obligations. Recent rows help identify whether the profile is still active in current procurement data.
- Award date: Not listed
Source caveats
- USAspending records can be revised after initial publication.
- Negative obligations and deobligations may affect totals in narrow slices.
Spending by Fiscal Year
| FY20261 awards | $15,337 |
| FY20252 awards | $1,253,293 |
| FY20244 awards | $2,756,439 |
| FY202311 awards | $265,921,691 |
| FY202213 awards | $250,814,368 |
| FY202124 awards | $394,384,643 |
Top Contractors
| EMERGENT BIODEFENSE OPERATIONS LANSING LLC1 awards | $211,409,788 |
| TRUSTEES OF BOSTON UNIVERSITY1 awards | $150,780,000 |
| ABSS SOLUTIONS INC1 awards | $113,293,528 |
| VEDANTA BIOSCIENCES, INC.1 awards | $79,146,088 |
| PRESIDENT AND FELLOWS OF HARVARD COLLEGE1 awards | $57,273,778 |
| DELOITTE CONSULTING LLP1 awards | $47,092,964 |
| VISBY MEDICAL, INC.1 awards | $41,169,014 |
| ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.1 awards | $34,081,098 |
| T2 BIOSYSTEMS, INC1 awards | $30,912,117 |
| FISHER BIOSERVICES INC1 awards | $29,417,403 |
Top Agencies
| Department of Health and Human Services33 awards | $783,000,952 |
| General Services Administration1 awards | $113,293,528 |
| Department of Defense9 awards | $16,834,503 |
| Department of the Interior2 awards | $1,120,325 |
| Department of Veterans Affairs10 awards | $896,460 |
Recent Awards
| Award | Recipient | Fiscal year | Obligations | Date |
|---|---|---|---|---|
| 75A50122C00047 | EMERGENT BIODEFENSE OPERATIONS LANSING LLC | 2023 | $211,409,788 | Not available |
| 75A50122C00028 | TRUSTEES OF BOSTON UNIVERSITY | 2022 | $150,780,000 | Not available |
| 47QFWA20C0012 | ABSS SOLUTIONS INC | 2021 | $113,293,528 | Not available |
| 75A50120C00177 | VEDANTA BIOSCIENCES, INC. | 2021 | $79,146,088 | Not available |
| 75N93019C00071 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2021 | $57,273,778 | Not available |
| 75F40122C00143 | DELOITTE CONSULTING LLP | 2022 | $47,092,964 | Not available |
| 75A50121C00019 | VISBY MEDICAL, INC. | 2021 | $41,169,014 | Not available |
| 75A50123F33007 | ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC. | 2023 | $34,081,098 | Not available |
| 75A50119C00053 | T2 BIOSYSTEMS, INC | 2021 | $30,912,117 | Not available |
| 75N93022C00023 | FISHER BIOSERVICES INC | 2022 | $29,417,403 | Not available |
Citation facts
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) has $915,145,769 in ingested federal contract obligations across 55 award records in this naics profile.
- Source
- USAspending.gov procurement award records
- Data updated
- May 7, 2026
- Canonical URL
- https://www.govspending.us/naics/541714
Federal Contract Questions
How much federal contract spending is associated with RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)?
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) has $915,145,769 in ingested contract obligations across 55 award records.
Which relationships matter most for RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)?
EMERGENT BIODEFENSE OPERATIONS LANSING LLC is the largest listed relationship in this profile at $211,409,788.
Which industries or buyers are most visible?
Department of Health and Human Services is the largest listed secondary category at $783,000,952.
Source: USAspending.gov. Last updated from ingested federal spending data: May 7, 2026.